Nalgosed, 10mg/ml, Solution for injection
Nalgosed, 10mg/ml, Solution for injection
Authorised
- Butorphanol
Product identification
Medicine name:
Nalgosed, 10mg/ml, Solution for injection
NALGOSED 10 mg/ml injekčný roztok
Active substance:
- Butorphanol
Target species:
-
Cat
-
Dog
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Butorphanol10.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cat
-
Dog
-
-
Intravenous use
-
Horse
-
Milk0day
-
Meat and offal0day
-
-
Cat
-
Dog
-
-
Subcutaneous use
-
Cat
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN02AF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Package description:
- Glass Vial 1 x 10.0 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/035/MR/19-S
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0142/001
Concerned member states:
-
Bulgaria
-
Estonia
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Poland
-
Romania
-
Slovakia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Slovak (PDF)
Published on: 7/02/2022
How useful was this page?: